Cargando…
Targeted treatment of folate receptor-positive platinum-resistant ovarian cancer and companion diagnostics, with specific focus on vintafolide and etarfolatide
Among the gynecological malignancies, ovarian cancer is the leading cause of mortality in developed countries. Treatment of ovarian cancer is based on surgery integrated with chemotherapy. Platinum-based drugs (cisplatin and carboplatin) comprise the core of first-line chemotherapy for patients with...
Autores principales: | Serpe, Loredana, Gallicchio, Margherita, Canaparo, Roberto, Dosio, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917542/ https://www.ncbi.nlm.nih.gov/pubmed/24516337 http://dx.doi.org/10.2147/PGPM.S58374 |
Ejemplares similares
-
Profile of vintafolide (EC145) and its use in the treatment of platinum-resistant ovarian cancer
por: Luyckx, Mathieu, et al.
Publicado: (2014) -
Recent Developments in Antibacterial Therapy: Focus on Stimuli-Responsive Drug-Delivery Systems and Therapeutic Nanoparticles
por: Canaparo, Roberto, et al.
Publicado: (2019) -
Ultrasound Triggers Hypericin Activation Leading to Multifaceted Anticancer Activity
por: Foglietta, Federica, et al.
Publicado: (2022) -
The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems
por: Foglietta, Federica, et al.
Publicado: (2021) -
Biomedical Applications of Reactive Oxygen Species Generation by Metal Nanoparticles
por: Canaparo, Roberto, et al.
Publicado: (2020)